Diabetes Medication

|

19

Novo Nordisk’s Ozempic® Lists on the Ontario Provincial Formulary

Novo Nordisk announced that Ozempic (semaglutide injection) is now publicly reimbursed in the province of Ontario for adults living with Type 2 …

Special Spotlight On Diabetes Prescription Drugs: Basaglar

Medically reviewed by Dena Westphalen, PharmD on July 30, 2019 — Written by Lindsay Slowiczek, PharmD.  Republished with permission …

Finding Ways to Improve Medication Adherence For Latinos with Diabetes

Latino adults have higher diabetes rates than non-Latinos, yet research shows they are less likely to correctly follow medication instructions …

Review Sheds New Light on Gangrene Cases Linked to Patients on SGLT2 Diabetes Drugs

A new review of Fournier Gangrene cases associated with SGLT2 diabetes drugs conducted by researchers is shedding new light on the occurrence of …

| | |

Janssen Submits sNDA for INVOKANA® for Chronic Kidney Disease in Patients with Type 2 Diabetes

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the …

|

Oramed Gets Patent for Key Aspect of Its Oral Delivery Technology in U.S.

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has …

Novo Nordisk Seeks U.S. FDA Approval for Oral Type 2 Diabetes Medication

Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for oral semaglutide, …

|

Diabetes drug effective against heart failure in wide spectrum of patients

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with …

Two Type 2 Diabetes Drugs Linked to Higher Risk of Heart Disease

Two drugs commonly prescribed to treat type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or …

|

Diabetes Drug Prevents Heart Failure; Kidney Risks

In the largest trial of its kind to determine the cardiovascular outcomes for a new class of diabetes medications, Astra Zeneca’s Farxiga was …